BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9033627)

  • 1. Endometrial cancer in relation to intra-uterine device use.
    Hill DA; Weiss NS; Voigt LF; Beresford SA
    Int J Cancer; 1997 Jan; 70(3):278-81. PubMed ID: 9033627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine device use and endometrial cancer risk.
    Sturgeon SR; Brinton LA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Lurain JR
    Int J Epidemiol; 1997 Jun; 26(3):496-500. PubMed ID: 9222773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive cervical cancer and intrauterine device use.
    Lassise DL; Savitz DA; Hamman RF; Barón AE; Brinton LA; Levines RS
    Int J Epidemiol; 1991 Dec; 20(4):865-70. PubMed ID: 1800424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine device use and risk of endometrial cancer.
    Parazzini F; La Vecchia C; Moroni S
    Br J Cancer; 1994 Oct; 70(4):672-3. PubMed ID: 7917915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current use of an intrauterine device and risk of tubal pregnancy.
    Rossing MA; Daling JR; Voigt LF; Stergachis AS; Weiss NS
    Epidemiology; 1993 May; 4(3):252-8. PubMed ID: 8512989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-uterine contraception and the risk of endometrial cancer.
    Castellsagué X; Thompson WD; Dubrow R
    Int J Cancer; 1993 Jul; 54(6):911-6. PubMed ID: 8335399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ever-use of the intra-uterine device and the risk of ovarian cancer.
    Balayla J; Gil Y; Lasry A; Mitric C
    J Obstet Gynaecol; 2021 Aug; 41(6):848-853. PubMed ID: 33045859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of IUDs is increasing.
    Finger WR; Barr D
    Netw Res Triangle Park N C; 1992 Oct; 13(2):27-30. PubMed ID: 12286082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant).
    Clark DA; Wang S; Rogers P; Vince G; Affandi B
    Hum Reprod; 1996 Jul; 11(7):1438-44. PubMed ID: 8671483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
    Mehanna MT; Rizk MA; Ramadan M; Schachter J
    Am J Obstet Gynecol; 1994 Sep; 171(3):691-3. PubMed ID: 8092216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe pain at interval IUD insertion: a case-control analysis of patient risk factors.
    Chi IC; Galich LF; Tauber PF; Wilkens LR; Waszak CS; Siemens AJ; Lippes J
    Contraception; 1986 Nov; 34(5):483-95. PubMed ID: 3816232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.
    Hasson HM; Berger GS; Edelman DA
    Am J Obstet Gynecol; 1976 Dec; 126(8):973-81. PubMed ID: 998687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of the data collection process for a multicenter, population-based, case-control design.
    Wingo PA; Ory HW; Layde PM; Lee NC
    Am J Epidemiol; 1988 Jul; 128(1):206-17. PubMed ID: 3381827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IUD use and the risk of endometrial cancer.
    Benshushan A; Paltiel O; Rojansky N; Brzezinski A; Laufer N
    Eur J Obstet Gynecol Reprod Biol; 2002 Nov; 105(2):166-9. PubMed ID: 12381481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptive and IUD use and endometrial cancer: a population-based case-control study in Shanghai, China.
    Tao MH; Xu WH; Zheng W; Zhang ZF; Gao YT; Ruan ZX; Cheng JR; Gao J; Xiang YB; Shu XO
    Int J Cancer; 2006 Nov; 119(9):2142-7. PubMed ID: 16823853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intrauterine device, pelvic inflammatory disease, and infertility: the confusion between hypothesis and knowledge.
    Grimes DA
    Fertil Steril; 1992 Oct; 58(4):670-3. PubMed ID: 1426307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.